ArticleFuture oncology (London, England)2025

Clinical representativeness of pivotal trials for T-cell engagers in relapsed/refractory follicular lymphoma.

Zhijie Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.